NEW YORK -- A vaccine for the new coronavirus should be ready for emergency use in early 2021, American drugmaker Johnson & Johnson announced Monday.
US drug company aims to supply 1bn doses worldwide

An employee tests for the coronavirus at a medical laboratory in Cologne, Germany, on March 24. © Reuters
NEW YORK -- A vaccine for the new coronavirus should be ready for emergency use in early 2021, American drugmaker Johnson & Johnson announced Monday.